glp 1 clinical studies The transformative breakthroughs in GLP-1 research recognized by the 2024 Lasker~DeBakey award | Current Medicine GLP1 agonists: current and future
Description
What comes first
In the current review, we discussed the dysregulation of IGF-1/GLP-1 signaling in neurodegenerative manifestations of ALS like a genetic anomaly, oligodendrocyte degradation, demyelination, glial overactivation, immune deregulation, and neuroexcitation
Leading up to #ASCO25, Monica Avila, MD, highlights promising research showing GLP-1 drugs may lower the risk of obesity-related cancers, especially in women with diabetes
SUPPORTS GLP 1 LEVELS AND GUT HEALTH: Eriomin is a unique citrus bioflavonoid extract that may help support digestive wellness by contributing to a balanced intestinal environment and support gut health as part of a healthy lifestyle
